Multiparametric MRI (mpMRI) for Preoperative Staging and Treatment Planning for Newly-Diagnosed Prostate Cancer
T
Temel Tirkes, MD
Primary Investigator
Not Recruiting
18 years - 100 years
Male
Phase
N/A
2 Locations
Brief description of study
This phase II trial studies how well multiparametric magnetic resonance imaging (MRI) works in evaluating cancer stage and helping treatment planning in patients with prostate cancer.
Detailed description of study
Multiparametric MRI may be useful for evaluating the type of cancer in finding aggressive disease.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Prostate Carcinoma, Prostate Cancer
-
Age: 18 years - 100 years
-
Gender: Male
Inclusion Criteria
Recently diagnosed with prostate cancer for whom definitive surgical treatment is indicated
Exclusion Criteria
Not suitable to undergo MRI or receive gadolinium-based contrast agent (severe, untreatable claustrophobia; MRI-incompatible metallic objects or implanted medical devices; renal failure; weight greater than allowable by scanner per institutional standard practice)
Prior surgical and/or non-surgical treatment for prostate cancer
Prior hip replacement or other major pelvic surgery
Updated on
01 Aug 2024.
Study ID: 1902624997 (RADY-ECOG-ACRIN-EA8171)
